Establishment of an efficacy-oriented quality grading framework for herbal medicines: Phyllanthus emblica as an example
- 13 March 2025
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 346, 119632
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82104126/H3410)
- China Postdoctoral Science Foundation (2024M762166)
This publication has 35 references indexed in Scilit:
- Tracing the origin of isatidis radix based on multivariate data fusion combined with DBN classification algorithmChemometrics and Intelligent Laboratory Systems, 2024
- Biomarkers of Hepatic Toxicity: An OverviewCurrent Therapeutic Research, 2024
- Phyllanthus emblica Linn: A comprehensive review of botany, traditional uses, phytonutrients, health benefits, quality markers, and applicationsFood Chemistry, 2024
- Amelioration of ethanol-induced oxidative stress and alcoholic liver disease by in vivo RNAi targeting Cyp2e1Acta Pharmaceutica Sinica B, 2023
- Dysregulation of tryptophan metabolism and distortion of cell signaling after oral exposure to ethanol and Kynurenic acidGene, 2022
- Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 yearsActa Pharmaceutica Sinica B, 2022
- Untargeted lipidomics analysis of Mori Fructus polysaccharide on acute alcoholic liver injury in mice using ultra performance liquid chromatography-quadrupole-orbitrap-high resolution mass spectrometryInternational Immunopharmacology, 2021
- COX-2 in liver fibrosisClinica Chimica Acta, 2020
- Approaches to establish Q-markers for the quality standards of traditional Chinese medicinesActa Pharmaceutica Sinica B, 2017
- Mechanism of Corilagin interference with IL-13/STAT6 signaling pathways in hepatic alternative activation macrophages in schistosomiasis-induced liver fibrosis in mouse modelEuropean Journal of Pharmacology, 2016